2seventy bio raises $170m in private placement

Cambridge, Massachusetts-based 2seventy bio Inc, a immuno-oncology cell therapy company, has inked a private placement of about $170 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this